674 related articles for article (PubMed ID: 18321598)
41. Linezolid for the treatment of a heteroresistant Staphylococcus aureus shunt infection.
Cook AM; Ramsey CN; Martin CA; Pittman T
Pediatr Neurosurg; 2005; 41(2):102-4. PubMed ID: 15942282
[TBL] [Abstract][Full Text] [Related]
42. Linezolid alone and in combination with rifampicin prevents experimental vascular graft infection due to methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
Sacar M; Sacar S; Kaleli I; Onem G; Turgut H; Goksin I; Ozcan V; Kaan Inan B; Duver H; Baltalarli A
J Surg Res; 2007 May; 139(2):170-5. PubMed ID: 17292421
[TBL] [Abstract][Full Text] [Related]
43. Methicillin-resistant Staphylococcus aureus in middle ear fluid of children.
Klein J; Chan S
Clin Pediatr (Phila); 2010 Jan; 49(1):66-8. PubMed ID: 19628757
[TBL] [Abstract][Full Text] [Related]
44. Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid.
Wareham DW; Abbas H; Karcher AM; Das SS
J Infect; 2006 Apr; 52(4):300-4. PubMed ID: 16099052
[TBL] [Abstract][Full Text] [Related]
45. Emergence of linezolid resistance in a methicillin resistant Staphylococcus aureus strain.
Hentschke M; Saager B; Horstkotte MA; Scherpe S; Wolters M; Kabisch H; Grosse R; Heisig P; Aepfelbacher M; Rohde H
Infection; 2008 Feb; 36(1):85-7. PubMed ID: 18165857
[No Abstract] [Full Text] [Related]
46. [A case of refractory deep incisional surgical site infection due to methicillin-resistant Staphylococcus aureus (MRSA) and successfully treated with oral linezolid].
Matsumoto H; Kawabata R; Kishimoto T; Yamamoto E; Kimura Y; Imamura H; Yamamoto T; Takemoto H; Fukunaga M; Ohzato H
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2441-3. PubMed ID: 23268104
[TBL] [Abstract][Full Text] [Related]
47. Pharmacokinetics and tolerance of linezolid for meticillin-resistant Staphylococcus aureus mediastinitis in paediatric patients.
Kosaka T; Kokufu T; Shime N; Sugioka N; Kato R; Hamaoka K; Fujita N
Int J Antimicrob Agents; 2009 Apr; 33(4):368-70. PubMed ID: 19097868
[TBL] [Abstract][Full Text] [Related]
48. Linezolid tissue penetration and serum activity against strains of methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in diabetic patients with foot infections.
Stein GE; Schooley S; Peloquin CA; Missavage A; Havlichek DH
J Antimicrob Chemother; 2007 Oct; 60(4):819-23. PubMed ID: 17673476
[TBL] [Abstract][Full Text] [Related]
49. Pharmacokinetics and pharmacodynamics of linezolid in children with cystic fibrosis.
Santos RP; Prestidge CB; Brown ME; Urbancyzk B; Murphey DK; Salvatore CM; Jafri HS; McCracken GH; Ahmad N; Sanchez PJ; Siegel JD
Pediatr Pulmonol; 2009 Feb; 44(2):148-54. PubMed ID: 19137597
[TBL] [Abstract][Full Text] [Related]
50. Efficacy of linezolid versus vancomycin in the treatment of methicillin-resistant Staphylococcus aureus discitis: a controlled animal model.
Conaughty JM; Chen J; Martinez OV; Chiappetta G; Brookfield KF; Eismont FJ
Spine (Phila Pa 1976); 2006 Oct; 31(22):E830-2. PubMed ID: 17047530
[TBL] [Abstract][Full Text] [Related]
51. An infection with linezolid-resistant S. aureus in a patient with left ventricular assist system.
Kola A; Kirschner P; Gohrbandt B; Chaberny IF; Mattner F; Strüber M; Gastmeier P; Suerbaum S
Scand J Infect Dis; 2007; 39(5):463-5. PubMed ID: 17464873
[TBL] [Abstract][Full Text] [Related]
52. Fungal causes of otitis externa and tympanostomy tube otorrhea.
Martin TJ; Kerschner JE; Flanary VA
Int J Pediatr Otorhinolaryngol; 2005 Nov; 69(11):1503-8. PubMed ID: 15927274
[TBL] [Abstract][Full Text] [Related]
53. EUCAST Technical Note on linezolid.
European Committee on Antimicrobial Susceptibility Testing (EUCAST) Steering Committee
Clin Microbiol Infect; 2006 Dec; 12(12):1243-5. PubMed ID: 17121637
[No Abstract] [Full Text] [Related]
54. A multicenter, open label, double tympanocentesis study of high dose cefdinir in children with acute otitis media at high risk of persistent or recurrent infection.
Arguedas A; Dagan R; Leibovitz E; Hoberman A; Pichichero M; Paris M
Pediatr Infect Dis J; 2006 Mar; 25(3):211-8. PubMed ID: 16511382
[TBL] [Abstract][Full Text] [Related]
55. Current bacteriology of chronic otitis media with effusion: high rate of nosocomial infection and decreased antibiotic sensitivity.
Jung H; Lee SK; Cha SH; Byun JY; Park MS; Yeo SG
J Infect; 2009 Nov; 59(5):308-16. PubMed ID: 19715725
[TBL] [Abstract][Full Text] [Related]
56. Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype.
Pillai SK; Sakoulas G; Wennersten C; Eliopoulos GM; Moellering RC; Ferraro MJ; Gold HS
J Infect Dis; 2002 Dec; 186(11):1603-7. PubMed ID: 12447736
[TBL] [Abstract][Full Text] [Related]
57. Methicillin-resistant Staphylococcus aureus endocarditis in an extremely low-birth-weight infant treated with linezolid.
Sung TJ; Kim HM; Kim MJ
Clin Pediatr (Phila); 2008 Jun; 47(5):504-6. PubMed ID: 18509151
[No Abstract] [Full Text] [Related]
58. Cost-effectiveness of linezolid and vancomycin in the treatment of surgical site infections.
Patanwala AE; Erstad BL; Nix DE
Curr Med Res Opin; 2007 Jan; 23(1):185-93. PubMed ID: 17257479
[TBL] [Abstract][Full Text] [Related]
59. Methicillin-resistant Staphylococcus aureus infection in a renal allograft recipient treated successfully with a novel new antimicrobial agent (linezolid): new treatment options for infections due to resistant organisms.
Antony SJ; Bitter KM; Moreland T; Raudales F; Diaz-Luna H
Clin Infect Dis; 1999 Nov; 29(5):1341-2. PubMed ID: 10524997
[No Abstract] [Full Text] [Related]
60. In vitro susceptibility of staphylococci to linezolid and other antimicrobial agents.
Poiată A; Tuchiluş C; Bădicuţ I; Grigore L; Buiuc D
Roum Arch Microbiol Immunol; 2002; 61(4):293-9. PubMed ID: 15055263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
